Small Molecule Inhibitor of CHFR
Application
Small molecule inhibitor of CHFR to increase taxane efficacy in cancer treatment.
Key Benefits
Combination treatment, potentially effective against cancers resistant to taxane treatment.
Market Summary
Microtubular-targeted chemotherapy agents such as taxanes are among the most widely prescribed first- and second- line chemotherapy...
Published: 7/28/2023
Contributor(s): Johann Brandes
|